SCHEMBL19145140

SCHEMBL19145140

N[S+]([O-])c1ccc(F)c([N+](=O)[O-])c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
HIF1A Q16665 1/20 0.55
VCAM1 P19320 1/20 0.51
ATM Q13315 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
LMNA P02545 7/20 0.41
HTT P42858 4/20 0.41
MAPT P10636 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GAA P10253 2/20 0.41
MITF O75030 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CA1 P00915 1/20 0.41
MMP2 P08253 1/20 0.41
CA14 Q9ULX7 1/20 0.41
GRM8 O00222 1/20 0.38
GRM6 O15303 1/20 0.38
GRM4 Q14833 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28337722 0.85 ALDH1A1 (0.58) ALDH1A1HIF1AVCAM1ATMTDP1
SCHEMBL9222965 0.82 ALDH1A1 (0.55) ALDH1A1HIF1AVCAM1ATMTDP1
SCHEMBL19956882 0.79 VCAM1 (0.53) ALDH1A1VCAM1TDP1MAPTMEN1
SCHEMBL27703189 0.75 ALDH1A1 (0.50) ALDH1A1TDP1LMNAHTTMAPT
SCHEMBL394329 0.73 ALDH1A1 (0.64) ALDH1A1HIF1AVCAM1ATMTDP1
SCHEMBL11756040 0.73 ALDH1A1 (0.46) ALDH1A1TDP1LMNAMAPTMEN1
SCHEMBL11579276 0.72 ALDH1A1 (0.67) ALDH1A1HIF1AVCAM1ATMTDP1
SCHEMBL102780 0.72 ATM (0.69) ALDH1A1HIF1AVCAM1ATMTDP1
SCHEMBL29462663 0.72 ATM (0.69) ALDH1A1HIF1AVCAM1ATMTDP1
SCHEMBL19182644 0.71 PDK1 (0.52) ALDH1A1HIF1ATDP1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2727038-B1 CRYSTAL STRUCTURE OF THE PRO FORM OF A MATRIX METALLOPROTEINASE AND AN ALLOSTERIC PROCESSING INHIBITOR JANSSEN PHARMACEUTICA NV (BE) 2017-07-26 EP disclosed
WO-2017123616-A1 INHIBITING B-CELL LYMPHOMA 2 (BCL-2) AND RELATED PROTEINS MERRIMACK PHARMACEUTICALS, INC. (US) 2017-07-20 WO disclosed